Table 1 Demographic and clinical data of the patients
Case number | Age | Diagnosis according to ILAR criteria | Age at Diagnosis (years) | Age at last visit (years) | Duration of Remission (months) | Clinical signs of SARS-CoV-2 infection | Affected joins | Estimated time between infection and arthritis flare | Medication |
|---|---|---|---|---|---|---|---|---|---|
1 | 7 | extended Oligoarthritis | 2.8 | 7.6 | 40.8 | none | right ankle | 3 weeks | none |
2 | 17 | Rheumatoid-factor negative Polyarthritis | 11.5 | 18.5 | 5.8 | none | both ankles and subtalar joints | 3 weeks | baricitinib |
3 | 9 | Seronegative Polyarthritis | 0.7 | 8.9 | 12.2 | fever, diarrhea | both knees, right ankle | 1 week | methotrexate, etanercept |
4 | 17 | Enthesitis-associated arthritis | 10.9 | 18.1 | 41.5 | respiratory symptoms, loss of taste | right knee, ankles, wrists, fingers | 4 weeks | none |
5 | 15 | extended Oligoarthritis | 2.9 | 15.6 | 20.5 | fever, respiratory symptoms | wrists, hips, knees, ankles | 4 weeks | golimumab, etanercept |